Figure 1From: ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xLMorphology and radiosensitivity of MDA-MB-231R cells. (A) No obvious change in the cell morphology was observed following radiation. (B) The radioresistant MDA-MB-231R cells had a higher survival rate than the non-radioresistant MDA-MB-231 cells.Back to article page